This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parwati, I.
Right arrow Articles by Zanden, A. v. d.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parwati, I.
Right arrow Articles by Zanden, A. v. d.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2003, p. 5350-5351, Vol. 41, No. 11
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.11.5350-5351.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

LETTERS TO THE EDITOR

Application of Spoligotyping to Noncultured Mycobacterium tuberculosis Bacteria Requires an Optimized Approach


arrow
LETTER
 
In a recent issue we read with interest the contribution of Zink et al. (7) on the characterization of Mycobacterium tuberculosis complex DNA in Egyptian mummies by spoligotyping (spacer oligotyping).

Compared with other PCR-based methods that combine detection and typing of such DNA, spoligotyping is more sensitive, because it targets the direct repeats (DRs) present in multiple (sometimes up to 60) copies in the genomic DR locus of M. tuberculosis complex bacteria. The well-conserved 36-bp DRs are interspersed with nonrepetitive spacer sequences of 34 to 41 bp in length (2, 3, 4). The variation in the presence of these spacer sequences among strains of the M. tuberculosis complex allows for the genotyping of mycobacterial DNA directly isolated from clinical samples without the need to culture these bacteria.

Kamerbeek et al. described spoligotyping for use with purified DNA from cultured strains (2). However, when this method was used to target extracted DNA from M. tuberculosis complex bacteria in clinical samples, some of the spacers showed weak hybridization signals. We detected no hybridization signals with a few clinical samples. This is proven by the comparison of the spoligotyping patterns produced from bacteria on a Ziehl-Neelsen (ZN) slide (in dilutions of 1:2, 1:4, and 1:8) with those seen with the method described by van der Zanden et al. (3) (see Fig. 1). Therefore, we optimized our PCR mixture for direct spoligotyping of M. tuberculosis complex DNA in clinical samples by using a concentration of 3.0 mM instead of 0.7 mM MgCl2, 15 mM instead of 5 mM Tris-HCl (pH 9.0), and 20 to 50 pmol of primer in PCR. The use of this adjusted protocol yielded a complete spoligotyping pattern for bacteria in clinical samples as compared to that seen with cultured bacteria (3).



View larger version (24K):
[in this window]
[in a new window]
  		FIG. 1. Comparison of spoligotyping patterns after the application of spoligotyping directly to ZN-stained slides by using the protocols of Kamerbeek et al. (2) and van der Zanden et al. (3). The extracted DNA of the ZN slides was used in the dilutions 1:2, 1:4, and 1:8 in the spoligotyping.

We also successfully used the optimized spoligotyping on bacteria from paraffin wax-embedded tissues (4, 5, 6) and from the mummified remains of humans found in an 18th century Hungarian crypt (1). To our surprise, in the current study of Zink et al. (7) the nonoptimized protocol of Kamerbeek et al. (2) was applied to study samples from Egyptian mummies without any modification of the PCR reagents. Hence, in the spoligotyping patterns no hybridization with spacers 2, 14, and 39 was found. We therefore again wish to emphasize that for a reliable and reproducible application of spoligotyping to M. tuberculosis complex bacteria in clinical samples, the optimized protocol (1, 3) should be used.


arrow
REFERENCES
 
    1
  1. Fletcher, H. A., H. D. Donoghue, M. Taylor, A. G. M. van der Zanden, and M. Spigelman. 2003. Molecular analysis of Mycobacterium tuberculosis DNA from a family of 18th century Hungarians. Microbiology 149:143-151.[Abstract/Free Full Text]
    2. 2
  2. Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914.[Abstract]
    3. 3
  3. van der Zanden, A. G. M., A. H. Hoentjen, F. G. C. Heilmann, E. F. Weltevreden, L. M. Schouls, and J. D. A. van Embden. 1998. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis complex in paraffin wax embedded tissues and in stained microscopic preparations. Mol. Pathol. 51:209-214.[Abstract]
    4. 4
  4. van der Zanden, A. G. M., K. Kremer, L. M. Schouls, K. Caimi, A. Cataldi, A. Hulleman, N. J. D. Nagelkerke, and D. van Soolingen. 2002. Improvement of differentiation and interpretability of spoligotyping for Mycobacterium tuberculosis complex isolates by introduction of new spacer oligonucleotides. J. Clin. Microbiol. 40:4628-4639.[Abstract/Free Full Text]
    5. 5
  5. van der Zanden, A. G. M., R. H. L. Rammeloo, F. J. Mud, T. A. J. M. Manschot, and D. van Soolingen. 2001. Disseminated Mycobacterium tuberculosis infection of the upper respiratory tract diagnosed by spoligotyping. Int. J. Tuberc. Lung Dis. 5:784-785.[Medline]
    6. 6
  6. van der Zanden, A. G. M., T. Bosje, F. G. C. Heilmann, and D. van Soolingen.2001. Nosocomial transmission of tuberculosis to a nurse demonstrated by means of spoligotyping of a formalin-fixed bronchial biopsy. Neth. J. Med. 59:152-157.[CrossRef][Medline]
    7. 7
  7. Zink, A. R., C. Sola, U. Reischl, W. Grabner, N. Rastogi, H. Wolf, and A. G. Nerlich. 2003. Characterization of Mycobacterium tuberculosis complex DNAs from Egyptian mummies by spoligotyping. J. Clin. Microbiol. 41:359-367.[Abstract/Free Full Text]
Ida Parwati1
Reinout van Crevel2
Dick van Soolingen3
Adri van der Zanden*
Division of Tropical and Infectious Diseases, Department of Clinical Pathology, Padjadjaran University, Bandung, Indonesia,1
Department of Internal Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands,2
Department of Mycobacteriology, National Institute of Public Health and the Environment, Bilthoven, The Netherlands,3
Medical Microbiology and Infectious Diseases, Gelre Hospitals, Apeldoorn, The Netherlands,4

* Phone: 31 55 5818560, Fax: 31 55 5818559, E-mail: agm.vd.zanden{at}wxs.nl.

Journal of Clinical Microbiology, November 2003, p. 5350-5351, Vol. 41, No. 11
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.11.5350-5351.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parwati, I.
Right arrow Articles by Zanden, A. v. d.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parwati, I.
Right arrow Articles by Zanden, A. v. d.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»